Mass spectrometry-based targeted proteomics for analysis of protein mutations.

Abstract excerpt

Cancers are caused by accumulated DNA mutations. This recognition of the central role of mutations in cancer and recent advances in next-generation sequencing, has initiated the massive screening of clinical samples and the identification of 1000s of cancer-associated gene mutations. However, proteomic analysis of the expressed mutation products lags far behind genomic (transcriptomic) analysis. With...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mass Spectrometry
• Share to Mutation
• Share to Peptides